Izrael - hebrajski - Ministry of Health

eisai israel ltd., israel - eribulin as mesilate - תמיסה להזרקה - eribulin as mesilate 0.44 mg/ml - eribulin - eribulin - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease. prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

Izrael - hebrajski - Ministry of Health

lavi industrial & medical agencies ltd. - מומחה - treatment of liver tumours / liver cancer

Izrael - hebrajski - Ministry of Health

lavi industrial & medical agencies ltd. - מומחה - brachytherapy (e.g.,treatment of prostate tumour & cancer)

Izrael - hebrajski - Ministry of Health

astra zeneca (israel) ltd - olaparib - קפסולה קשיחה - olaparib 50 mg - olaparib

Izrael - hebrajski - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - pembrolizumab - תרכיז להכנת תמיסה לאינפוזיה - pembrolizumab 25 mg/ml - pembrolizumab

Izrael - hebrajski - Ministry of Health

lavi industrial & medical agencies ltd. - צוות טכני - treatment of various cancers, tumors, non-malignant tumors & benign tumors

Izrael - hebrajski - Ministry of Health

syneron mdical ltd. - מומחה - laser systems for dermatologic and aesthetic treatments

Izrael - hebrajski - Ministry of Health

טבע מדיקל (שיווק) בע"מ - אחות - מערכת לעירוי תוך ורידי

Izrael - hebrajski - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

Izrael - hebrajski - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.